A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non–small-cell lung cancer (a Vanderbilt cancer center affiliate network study)
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 47 (4) , 931-937
- https://doi.org/10.1016/s0360-3016(00)00420-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta-analysisCancer, 1996
- Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90-15Cancer, 1995
- Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1995
- Investigation of taxol as a potential radiation sensitizerCancer, 1993
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Taxol binds to cellular microtubules.The Journal of cell biology, 1982
- Taxol binds to polymerized tubulin in vitroThe Journal of cell biology, 1981
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976